Close Menu

NEW YORK — Italian oncology genetics company Impact Lab Group said on Tuesday that it has agreed to acquire HeartGenetics, a developer of bioinformatic software and personalized genetic tests.

Cantanhede, Portugal-based HeartGenetics offers a range of genetic tests and services including ones for general wellness, cardiovascular conditions including hereditary thrombophilia and hypertrophic cardiomyopathy, and pharmacogenetics. Impact said the acquisition will broaden its portfolio of test panels and expand its presence in Spain, Portugal, and South America.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.